JRCT ID: jRCTs042180022
Registered date:20/12/2018
On-line 3-dimensional OPTical frequency domain IMaging to optimize bifurcation stenting using UltiMaster stent
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | coronary artery disease (CAD) patients undergoing coronary stent implantation. |
Date of first enrollment | 08/06/2017 |
Target sample size | 106 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Bifurcation PCI optimized by online-3D OFDI during and after procedure |
Outcome(s)
Primary Outcome | Post-procedural percentage of malapposed struts assessed by OFDI in bifurcation segment of main vessel |
---|---|
Secondary Outcome | Not applicable |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1. Patient is at least 18 years of age and signed Informed Consent 2. Subject has coronary artery disease involving a bifurcation with objective evidence of ischemia including patients with chronic stable angina, silent ischemia and NSTE-ACS 3. Subject is appropriate to be treated by PCI according to the local practice (judgment of operator or heart team decision) 4. Patients residence is in the area covered by the hospital 5. Patients with angiographically significant stenosis (>50 % by visual assessment) in de novo, native, previously unstented bifurcation lesion(s) including left main lesion, which is in opinion of operator appropriate to be treated by PCI with a single stent strategy 6. The size of main vessel matches available Ultimaster stent sizes (2.25-4.0 mm in diameter by visual assessment). 7. The size of side branch is >2.0mm in diameter by visual assessment. 8. The sidebranch is treatable with a sidebranch fenestration and/or kissing balloon |
Exclude criteria | 1. Pregnancy 2. Patients with ST elevation myocardial infarction 3. Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, sirolimus, contrast material 4. Known thrombocytopenia (platelet count< 100,000/mm3) 5. Cardiogenic Shock 6. Significant comorbidities precluding clinical follow-up (as judged by investigators) 7. Major planned surgery that requires discontinuation of dual antiplatelet therapy 8. History of stenting in the target bifurcation lesion 9. Renal insufficiency (GFR/MDRD <45 ml/min), which precludes in opinion of operator contrast injection during repeat OFDI pullback 10. Severely tortuous or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal optical frequency domain imaging (OFDI) or excessive risk of complication to place an OFDI catheter. 11. Target lesion reference vessel diameter (RVD) < 2.25 and > 4 mm 12. Others, Patient judged inappropriate by the attending physician |
Related Information
Primary Sponsor | Ozaki Yukio |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Terumo Corporation |
Secondary ID(s) | UMIN000024847 / NCT02972489 |
Contact
Public contact | |
Name | Takashi Muramatsu |
Address | 1-98 Dengakugakubo, Kutsukake, Toyoake, Japan Aichi Japan 470-1192 |
Telephone | +81-562-93-2312 |
takam@fujita-hu.ac.jp | |
Affiliation | Fujita Health University Hospital |
Scientific contact | |
Name | Yukio Ozaki |
Address | 1-98 Dengakugakubo, Kutsukake, Toyoake, Japan Aichi Japan 470-1192 |
Telephone | +81-562-93-2312 |
ozakiyuk@fujita-hu.ac.jp | |
Affiliation | Fujita Health University Hospital |